Literature DB >> 23532769

Characterization of in vitro expanded bone marrow-derived mesenchymal stem cells isolated from experimental autoimmune encephalomyelitis mice.

Dimitra Zacharaki1, Roza Lagoudaki, Olga Touloumi, Konstantia Kotta, Antiopi Voultsiadou, Kyriaki-Nepheli Poulatsidou, Athanasios Lourbopoulos, Georgios Hadjigeorgiou, Efthimios Dardiotis, Dimitris Karacostas, Nikolaos Grigoriadis.   

Abstract

Extensive experimental studies indicate that autologous bone marrow mesenchymal stem cells (BMSCs) are able to ameliorate experimental autoimmune encephalomyelitis (EAE) and potentially multiple sclerosis. However, the impact that the inflammatory environment present in EAE may have on the biological properties of BMSCs expanded in vitro for transplantation is yet to be clarified. It was investigated whether BMSCs isolated from EAE-induced C57bl6/J mice and expanded in vitro preserve the properties of BMSCs isolated from healthy donors (BMSCs-control). The mesenchymal origin, the differentiation potential, and the transcriptional expression profile of six histone-modifying genes were studied in both groups of BMSCs. BMSCs-EAE exhibited distinct morphology and larger size compared to BMSCs-control, higher degree of proliferation and apoptosis, differences in the adipogenesis and the osteogenesis induction, and differential expression of stromal markers and markers of progenitor and mature neuronal/glial cells. Moreover, BMSCs-EAE exhibited different expression patterns on a number of histone-modifying genes compared to controls. We recorded manifold differences, both phenotypical and functional, of in vitro expanded BMSCs-EAE in comparison to their healthy donor-derived counterparts that may be attributed to the inflammatory environment they originated from. Whether our findings may be of any clinical relevance needs to be clarified in future studies, in vivo.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23532769     DOI: 10.1007/s12031-013-9992-9

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  54 in total

Review 1.  Role of histone acetylation in cell physiology and diseases: An update.

Authors:  Shahper N Khan; Asad U Khan
Journal:  Clin Chim Acta       Date:  2010-06-23       Impact factor: 3.786

Review 2.  Mesenchymal stem cells for multiple sclerosis: does neural differentiation really matter?

Authors:  Antonio Uccelli; Sara Morando; Silvia Bonanno; Ivan Bonanni; Alessandro Leonardi; Gianluigi Mancardi
Journal:  Curr Stem Cell Res Ther       Date:  2011-03       Impact factor: 3.828

Review 3.  Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer.

Authors:  Saverio Minucci; Pier Giuseppe Pelicci
Journal:  Nat Rev Cancer       Date:  2006-01       Impact factor: 60.716

Review 4.  Mesenchymal stem cells: a new strategy for immunosuppression?

Authors:  Antonio Uccelli; Vito Pistoia; Lorenzo Moretta
Journal:  Trends Immunol       Date:  2007-04-02       Impact factor: 16.687

5.  Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis.

Authors:  P Cipriani; S Guiducci; I Miniati; M Cinelli; S Urbani; A Marrelli; V Dolo; A Pavan; R Saccardi; A Tyndall; R Giacomelli; M Matucci Cerinic
Journal:  Arthritis Rheum       Date:  2007-06

6.  Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting.

Authors:  Alma J Nauta; Geert Westerhuis; Alwine B Kruisselbrink; Ellie G A Lurvink; Roel Willemze; Willem E Fibbe
Journal:  Blood       Date:  2006-05-11       Impact factor: 22.113

7.  Adult bone marrow stromal cells differentiate into neural cells in vitro.

Authors:  J Sanchez-Ramos; S Song; F Cardozo-Pelaez; C Hazzi; T Stedeford; A Willing; T B Freeman; S Saporta; W Janssen; N Patel; D R Cooper; P R Sanberg
Journal:  Exp Neurol       Date:  2000-08       Impact factor: 5.330

8.  Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis.

Authors:  M-C Kastrinaki; P Sidiropoulos; S Roche; J Ringe; S Lehmann; H Kritikos; V-M Vlahava; B Delorme; G D Eliopoulos; C Jorgensen; P Charbord; T Häupl; D T Boumpas; H A Papadaki
Journal:  Ann Rheum Dis       Date:  2007-10-05       Impact factor: 19.103

9.  p53, cellular proliferation, and apoptosis-related factors in thymic neuroendocrine tumors.

Authors:  Anthony A Gal; Mary N Sheppard; John D L Nolen; Cynthia Cohen
Journal:  Mod Pathol       Date:  2004-01       Impact factor: 7.842

10.  Abnormal histone modification patterns in lupus CD4+ T cells.

Authors:  Nan Hu; Xiangning Qiu; Yongqi Luo; Jun Yuan; Yaping Li; Wenzhi Lei; Guiying Zhang; Ying Zhou; Yuwen Su; Qianjin Lu
Journal:  J Rheumatol       Date:  2008-04-01       Impact factor: 4.666

View more
  4 in total

1.  Shrinkage-mediated imaging of entire organs and organisms using uDISCO.

Authors:  Chenchen Pan; Ruiyao Cai; Francesca Paola Quacquarelli; Alireza Ghasemigharagoz; Athanasios Lourbopoulos; Paweł Matryba; Nikolaus Plesnila; Martin Dichgans; Farida Hellal; Ali Ertürk
Journal:  Nat Methods       Date:  2016-08-22       Impact factor: 28.547

2.  CNS disease diminishes the therapeutic functionality of bone marrow mesenchymal stem cells.

Authors:  Alex Sargent; Lianhua Bai; Genevieve Shano; Molly Karl; Eric Garrison; Lahiru Ranasinghe; Sarah M Planchon; Jeffrey Cohen; Robert H Miller
Journal:  Exp Neurol       Date:  2017-06-09       Impact factor: 5.330

Review 3.  Mesenchymal stem cells and induced pluripotent stem cells as therapies for multiple sclerosis.

Authors:  Juan Xiao; Rongbing Yang; Sangita Biswas; Xin Qin; Min Zhang; Wenbin Deng
Journal:  Int J Mol Sci       Date:  2015-04-24       Impact factor: 5.923

4.  Bone mesenchymal stem cells contributed to the neointimal formation after arterial injury.

Authors:  Mincai Li; Suqin Li; Liangzhu Yu; Jiliang Wu; Tonghui She; Yaping Gan; Zhenwu Hu; Wenli Liao; Hongli Xia
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.